Carole Hélissey

Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer

Ronald de Wit, Johann S. de Bono, Cora N. Sternberg et al. · New England Journal of Medicine · 2019 · 634 citations · Full text

Acute pulmonary embolism in non-hospitalized COVID-19 patients referred to CTPA by emergency department

A. Gervaise, C. Bouzad, Evelyne Péroux et al. · European Radiology · 2020 · 107 citations · Full text

Immunotherapy for cancer in people living with HIV

Jean‐Philippe Spano, Marianne Veyri, Aurélien Gobert et al. · AIDS · 2019 · 70 citations

<i>Escherichia coli</i> –Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer

Anne‐Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva et al. · Cancer Discovery · 2022 · 70 citations · Full text

Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study

Karim Fizazi, Gero Kramer, Jean-Christophe Eymard et al. · The Lancet Oncology · 2020 · 65 citations · Full text

Quality Of Life, Metastatic Prostate Cancer, Urology +8